Hidaka T, Yoshioka T, Uchida H, Yoshiya K, Tanaka T, Hirohashi S, Matsuo N, Nishimine K, Ohishi H, Hirao Y
Department of Radiology, Daiyukai General Hospital.
Nihon Igaku Hoshasen Gakkai Zasshi. 1994 Oct 25;54(12):1107-15.
Renal ablation by transcatheter renal arterial embolization (TAE) was performed in 10 patients with benign renal disease (hydronephrosis n = 6; renovascular hypertension n = 3; nephrotic syndrome n = 1). Each affected kidney had little or no renal function. Six patients with hydronephrosis were treated with TAE using absolute ethanol alone in three patients and the combination of absolute ethanol and gelatin sponge in the other three. Each patient was followed by sclerotherapy of the pelvocalyceal system via nephrostomy using absolute ethanol. In four of the six patients, the embolized kidney had no urine, and there was very little urine in the remaining two. The size of the embolized kidney was markedly decreased on CT. The three patients with renovascular hypertension were pre-studied by selective and renal vein sampling for PRA, and the kidney excreting higher renin was embolized by TAE with absolute ethanol. Blood pressure has become manageable without antihypertensive drug in two patients and with a reduced amount of drug in one. The patient with nephrotic syndrome had end stage renal failure and showed significant protein excretion. To prevent further protein loss, both kidneys were embolized with stainless steel coils. Urine output was significantly decreased, and consequently, hypoalbuminemia improved. All patients tolerated the procedure well, and there were no significant complications. Renal ablation by TAE may be an alternative to surgical treatment in selected patients with benign renal disease, particularly in patients with contraindications to surgery and in the elderly. Absolute ethanol and gelatin sponge seem safe and effective for TAE in patients with hydronephrosis and renovascular hypertension. For hydronephrosis, we recommend combining TAE with sclerotherapy of the pelvocalyceal system via nephrostomy using absolute ethanol. Though we successfully applied steel coil for the patient with nephrotic syndrome, absolute ethanol may be equally effective.
对10例患有良性肾脏疾病的患者进行了经导管肾动脉栓塞术(TAE)肾消融治疗(肾盂积水6例;肾血管性高血压3例;肾病综合征1例)。每个患肾的肾功能很少或几乎没有。6例肾盂积水患者接受了TAE治疗,其中3例仅使用无水乙醇,另外3例使用无水乙醇和明胶海绵联合治疗。每位患者随后通过肾造瘘术使用无水乙醇对肾盂肾盏系统进行硬化治疗。6例患者中有4例栓塞后的肾脏无尿液,其余2例尿液极少。CT显示栓塞后肾脏的体积明显缩小。3例肾血管性高血压患者术前通过选择性肾静脉采样检测肾素活性(PRA),对分泌较高肾素的肾脏用无水乙醇进行TAE栓塞。2例患者的血压在未使用降压药的情况下得到控制,1例患者所需降压药量减少。肾病综合征患者已处于终末期肾衰竭,蛋白排泄显著。为防止进一步的蛋白丢失,双侧肾脏均用不锈钢圈进行栓塞。尿量显著减少,因此低蛋白血症得到改善。所有患者对该手术耐受性良好,且无明显并发症。对于部分患有良性肾脏疾病的患者,尤其是有手术禁忌证的患者和老年患者,TAE肾消融可能是手术治疗的一种替代方法。无水乙醇和明胶海绵对肾盂积水和肾血管性高血压患者的TAE治疗似乎安全有效。对于肾盂积水,我们建议将TAE与通过肾造瘘术使用无水乙醇对肾盂肾盏系统进行硬化治疗相结合。虽然我们成功地对肾病综合征患者应用了钢圈,但无水乙醇可能同样有效。